Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00137254 | 0.0280662 | 0.0276876 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.00137565 | 0.0284555 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.00137565 | 0.0284555 | 1 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.0091505 | 1 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.00137565 | 0.0284555 | 0.5 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.00137565 | 0.0284555 | 1 |
Leishmania major | p-glycoprotein e | 0.00137565 | 0.0284555 | 0.5 |
Trypanosoma brucei | multidrug resistance protein E | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0091505 | 1 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.00137565 | 0.0284555 | 0.0280771 |
Schistosoma mansoni | multidrug resistance protein | 0.00137565 | 0.0284555 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00137565 | 0.0284555 | 0.5 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.00137565 | 0.0284555 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0091505 | 1 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.00137565 | 0.0284555 | 0.5 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.00137565 | 0.0284555 | 0.5 |
Brugia malayi | ABC transporter transmembrane region family protein | 0.00137565 | 0.0284555 | 0.5 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.00137565 | 0.0284555 | 1 |
Giardia lamblia | ABC transporter, putative | 0.00137565 | 0.0284555 | 1 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.00137565 | 0.0284555 | 1 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.00137565 | 0.0284555 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0091505 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0091505 | 1 | 1 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.00137565 | 0.0284555 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.00137565 | 0.0284555 | 1 |
Giardia lamblia | MRP-like ABC transporter | 0.00137565 | 0.0284555 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.00137565 | 0.0284555 | 0.5 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.00137565 | 0.0284555 | 0.5 |
Entamoeba histolytica | ABC transporter, putative | 0.00137565 | 0.0284555 | 0.5 |
Leishmania major | pentamidine resistance protein 1 | 0.00137565 | 0.0284555 | 0.5 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00137565 | 0.0284555 | 0.0280771 |
Leishmania major | ABC-thiol transporter | 0.00137565 | 0.0284555 | 0.5 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.00137565 | 0.0284555 | 0.5 |
Trypanosoma brucei | p-glycoprotein | 0.00137565 | 0.0284555 | 0.5 |
Brugia malayi | multidrug resistance related protein 1 | 0.00137565 | 0.0284555 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00137565 | 0.0284555 | 0.0280771 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence. | ChEMBL. | 22096101 | |
CC50 (functional) | > 100 uM | Huh7 cytotoxicity for Pf inhibitors | Novartis-GNF Malaria Box. | No reference |
CC50 | > 100 uM | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | ChEMBL. | 18579783 |
EC50 (functional) | = 0.3106 uM | W2 Pf proliferation inhibition | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.3106 uM | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
EC50 (functional) | = 0.468 uM | PF proliferation inhibition 3D7 | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.468 uM | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
IFI promiscuity index | = 0.07692 | IFI promiscuity index | Novartis-GNF Malaria Box. | No reference |
Potency (functional) | 0.5012 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.6511 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 5.2213 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.9953 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.8876 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 18579783 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.